Logo image of MTAL

MAC COPPER LTD (MTAL) Stock Fundamental Analysis

NYSE:MTAL - New York Stock Exchange, Inc. - JE00BQBC8469 - Common Stock - Currency: USD

10.13  +0.21 (+2.12%)

Fundamental Rating

2

Taking everything into account, MTAL scores 2 out of 10 in our fundamental rating. MTAL was compared to 150 industry peers in the Metals & Mining industry. MTAL has a bad profitability rating. Also its financial health evaluation is rather negative. MTAL does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

MTAL had negative earnings in the past year.
In the past year MTAL had a positive cash flow from operations.
MTAL Yearly Net Income VS EBIT VS OCF VS FCFMTAL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 -50M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of -10.88%, MTAL is doing worse than 69.72% of the companies in the same industry.
The Return On Equity of MTAL (-33.10%) is worse than 77.46% of its industry peers.
Industry RankSector Rank
ROA -10.88%
ROE -33.1%
ROIC N/A
ROA(3y)-2.92%
ROA(5y)N/A
ROE(3y)-17.17%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MTAL Yearly ROA, ROE, ROICMTAL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 -10 -20 -30 -40 -50

1.3 Margins

MTAL has a Gross Margin (11.22%) which is comparable to the rest of the industry.
MTAL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 11.22%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MTAL Yearly Profit, Operating, Gross MarginsMTAL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 -20 -40 -60 -80

More info and screens

1

2. Health

2.1 Basic Checks

MTAL does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MTAL has been increased compared to 1 year ago.
MTAL has a worse debt/assets ratio than last year.
MTAL Yearly Shares OutstandingMTAL Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 10M 20M 30M 40M 50M
MTAL Yearly Total Debt VS Total AssetsMTAL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of 0.25, we must say that MTAL is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.25, MTAL is not doing good in the industry: 79.58% of the companies in the same industry are doing better.
MTAL has a debt to FCF ratio of 132.38. This is a negative value and a sign of low solvency as MTAL would need 132.38 years to pay back of all of its debts.
MTAL has a Debt to FCF ratio (132.38) which is in line with its industry peers.
MTAL has a Debt/Equity ratio of 0.85. This is a neutral value indicating MTAL is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.85, MTAL is not doing good in the industry: 86.62% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF 132.38
Altman-Z 0.25
ROIC/WACCN/A
WACC9.8%
MTAL Yearly LT Debt VS Equity VS FCFMTAL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 0.84 indicates that MTAL may have some problems paying its short term obligations.
MTAL has a Current ratio of 0.84. This is amonst the worse of the industry: MTAL underperforms 87.32% of its industry peers.
MTAL has a Quick Ratio of 0.84. This is a bad value and indicates that MTAL is not financially healthy enough and could expect problems in meeting its short term obligations.
MTAL's Quick ratio of 0.69 is on the low side compared to the rest of the industry. MTAL is outperformed by 84.51% of its industry peers.
Industry RankSector Rank
Current Ratio 0.84
Quick Ratio 0.69
MTAL Yearly Current Assets VS Current LiabilitesMTAL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 50M 100M 150M 200M 250M

More info and screens

3

3. Growth

3.1 Past

MTAL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1955.36%.
EPS 1Y (TTM)-1955.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-205.15%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%880.62%

3.2 Future

Based on estimates for the next years, MTAL will show a very strong growth in Earnings Per Share. The EPS will grow by 23.58% on average per year.
Based on estimates for the next years, MTAL will show a quite strong growth in Revenue. The Revenue will grow by 10.16% on average per year.
EPS Next Y66.92%
EPS Next 2Y58.58%
EPS Next 3Y44.43%
EPS Next 5Y23.58%
Revenue Next Year25.84%
Revenue Next 2Y22.67%
Revenue Next 3Y20.25%
Revenue Next 5Y10.16%

3.3 Evolution

MTAL Yearly Revenue VS EstimatesMTAL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M 500M
MTAL Yearly EPS VS EstimatesMTAL Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 -0.5 1 -1

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

MTAL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
MTAL is valuated rather expensively with a Price/Forward Earnings ratio of 19.35.
The rest of the industry has a similar Price/Forward Earnings ratio as MTAL.
The average S&P500 Price/Forward Earnings ratio is at 22.44. MTAL is around the same levels.
Industry RankSector Rank
PE N/A
Fwd PE 19.35
MTAL Price Earnings VS Forward Price EarningsMTAL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

MTAL's Enterprise Value to EBITDA ratio is in line with the industry average.
MTAL's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 218.1
EV/EBITDA 16.37
MTAL Per share dataMTAL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as MTAL's earnings are expected to grow with 44.43% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y58.58%
EPS Next 3Y44.43%

More info and screens

0

5. Dividend

5.1 Amount

MTAL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MAC COPPER LTD

NYSE:MTAL (3/4/2025, 11:45:06 AM)

10.13

+0.21 (+2.12%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)10-21 2024-10-21/amc
Earnings (Next)04-28 2025-04-28/bmo
Inst Owners41.12%
Inst Owner Change94.88%
Ins Owners2.87%
Ins Owner ChangeN/A
Market Cap702.52M
Analysts84
Price Target18.49 (82.53%)
Short Float %3.35%
Short Ratio7.87
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.32%
PT rev (3m)3.57%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-76.78%
EPS NY rev (3m)-728.57%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-3.31%
Revenue NY rev (3m)-3.5%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 19.35
P/S 4.42
P/FCF 218.1
P/OCF 13.12
P/B 1.61
P/tB 1.61
EV/EBITDA 16.37
EPS(TTM)-2.88
EYN/A
EPS(NY)0.52
Fwd EY5.17%
FCF(TTM)0.05
FCFY0.46%
OCF(TTM)0.77
OCFY7.62%
SpS2.29
BVpS6.3
TBVpS6.3
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -10.88%
ROE -33.1%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 11.22%
FCFM 2.03%
ROA(3y)-2.92%
ROA(5y)N/A
ROE(3y)-17.17%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF 132.38
Debt/EBITDA 5.44
Cap/Depr 61.44%
Cap/Sales 31.64%
Interest Coverage N/A
Cash Conversion 78.63%
Profit Quality N/A
Current Ratio 0.84
Quick Ratio 0.69
Altman-Z 0.25
F-Score6
WACC9.8%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1955.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-205.15%
EPS Next Y66.92%
EPS Next 2Y58.58%
EPS Next 3Y44.43%
EPS Next 5Y23.58%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%880.62%
Revenue Next Year25.84%
Revenue Next 2Y22.67%
Revenue Next 3Y20.25%
Revenue Next 5Y10.16%
EBIT growth 1Y-489.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1243.69%
EBIT Next 3Y172.89%
EBIT Next 5Y79.51%
FCF growth 1Y228.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y2241.32%
OCF growth 3YN/A
OCF growth 5YN/A